Stay Informed

Welcome to the [SOCITEY NAME] publication page, your go-to source for the most up-to-date and relevant dental news stories. We are committed to keeping you informed about the latest advancements, research, and trends in oral health care.

By visiting our publication page regularly, you'll stay informed, inspired, and connected to the dynamic world of dentistry. Our goal is to empower you with the knowledge and resources you need to provide the highest quality of care to your patients.

Buprenorphine - Expedited Authorization and Emergency Fill Policy

Mar 4, 2020
Please read the following update from the HCA:

The Health Care Authority (HCA) would like to remind providers of the Washington Apple Health fee-for-service (FFS) expedited authorization (EA) criteria for buprenorphine monotherapy for pregnant clients. This EA allows pharmacies to submit a claim for a seven (7) day supply without a prior authorization. After submitting a claim with this EA, pharmacies and/or providers should request a prior authorization for further fills.

Drug Code Criteria
Buprenorphine
077
Seven (7) day induction of buprenorphine monotherapy for pregnant clients

In addition to the EA criteria, pharmacists also have the option to dispense an emergency fill, at the discretion of the pharmacist, for any medication to meet the immediate and/or urgent needs of the client, including prescriptions for buprenorphine monotherapy.

For clients enrolled in Apple Health managed care plan, contact the client’s plan.

Resources:

HCA’s Buprenorphine Containing Products Policy
Apple Health FFS EA list
HCA’s Emergency Fill Policy

For additional questions, email: applehealthpharmacypolicy@hca.wa.gov.